Post Graduation in Ayush Discipline. OR Post Graduation in Ayurveda Biology. OR Post Graduation in Pharmacology, Biotechnology, Bio-informatics, Molecular Biology.
M.Pharm or M.S in Pharmaceutics, Pharmaceutical Analysis, QA ; CSIR, GPAT, or GATE qualified or any other National-level examination conducted by the central government.
M.Sc. in Life Science /Nursing/ Biotechnology/ Microbiology /M. Pharma or equivalent. Candidate should have at least 6 year experience with Clinical Research Projects in academic setting and proficiency in English and Hindi language.
Master degree in Natural / Life Science form recognized university. Candidate with at least 2 years experience in Molecular / Cell Biology, sanger analysis & NGS Analysis will be preferred.
The candidate must hold an M.Sc. Botany, Biotechnology, Microbiology, Life Science, Applied Microbiology, biochemistry with first division in undergraduate and post graduate examination.
Masters Degree in Natural Sciences from a recognized University or equivalent. Hands-on research experience of genomics-based investigations of human samples from disease cohort.
Immacule Lifesciences has become a renowned name in the pharmaceutical industry. Breakdown & Preventive Maintenance of IMA Line equipment such as Vial Washing, Tunnel, Filling Machines, Vessels, and Autoclaves.
Define and execute the discovery biology strategy across modalities small molecules, antibody, ADC, and cell & gene therapy in alignment with company goals.
Gufic Biosciences Ltd is a leading pharmaceutical industry since 1970 and is one of the world’s largest Lyophilization injectables & wide range of API products, at Navsari (Gujarat)
Stryker a global leader in medical technologies, announced the expansion of its R&D presence in India with the opening of a new facility in Whitefield, Bengaluru. Building on its existing 220,000-square-foot R&D campus in Gurgaon, the new 140,000-square-foot facility further strengthens Stryker’s footprint in the country.
The United Kingdom, long considered a hub for pharmaceutical innovation, is facing an exodus of major pharmaceutical companies. Over the last several months, some of the industry biggest names, including Merck MSD, AstraZeneca, and Eli Lilly, have either cancelled or paused multi-million-pound projects
M.Pharm, M.S.(Pharm) with 55% marks and passing of NET/GATE/GPAT test. Supramolecular phospholipid complexed antifungal Nanoparticles for localized and Effective treatment of vulvovaginal Candidiasis